3
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Overview: Therapeutic Uses of Cell-Matrix Adhesive Proteins

&
Pages 1117-1140 | Published online: 03 Mar 2008

References to primary literature

  • BURRIDGE K, FATH K: Focal contacts: Trans-membrane links between the extracellu-lar matrix and the cytoskeleton. BioEssays (1989) 10(4):104–108.
  • LUNA EJ, Hrrr AL: Cytoskeleton-plasma membrane interactions. Science (1992) 258:955–963.
  • JAKEN S, LEACH K, KLAUCK T: Association of type 3 protein kinase C with focal contacts in rat embryo fibroblasts. J. Cell. Biol. (1989) 109:697–704.
  • HANKS S, CALALB M, HARPER M, PATEL S: Focal adhesion protein-tyrosine kinase phos-phorylated in response to cell attachment to fibronectin. Proc. Natl. Acad. Sci. (1992) 89:8487–8491.
  • cDNA cloning used to identify a non-membrane-spanning focal adhesion kinase (FadK) which is phosphorylated on tyrosine within minutes of exposure of cells to immobi-lized Fn.
  • KORNBERG L, EARP H, PARSONS J, SCHALLER M, JULIANO R: Cell adhesion or integrin clus-tering increases phosphorylation of a focal adhesion-associated tyrosine kinase. J. Biol. Chem. (1992) 267:23439–23442.
  • KLEuSS C, HESCHELER J, EWEL C, ROSENTHAL W, SCHULTS G, Wrrno B: Assignment of G-protein subtypes to specific receptors induc-ing inhibition of calcium currents. Nature (1991) 353:43–48.
  • SCHWARTZ M, INGBER D, LAWRENCE M, SPRINGER T, LECHENE C: Multiple integrins share the ability to induce elevation of intracellular pH. Exp. Cell Res. (1991) 195:533–535.
  • YAMADA KM: Adhesive recognition sequences.J. Biol. Chem. (1991) 266:12809–12812.
  • RUOSLAHTI E, PIERSCHBACHER M: New Per-spectives in Cell Adhesion: RGD and Inte-grins. Science (1987) 238:491–497.
  • THIERY J-P, DUBAND J-L, DUFOUR S, SAVAGNER P, IMHOF B: Roles of Fibronectin in embryo-genesis in Biology of Extracellular Matrix: A Series: Fibronectin (1989) Mosher D (Ed), Academic Press, San Diego.
  • McCowin( BA, ZETTER BR: Adhesive inter-actions in angiogenesis and metastasis. Phar-mac. Ther. (1992) 53:239–260.
  • Review of neovascularization and endothelial cell biology from the standpoint of CMAPs.
  • FAWCETT J, HARRIS A: Cell adhesion molecules and cancer. Curt: Opin. Oncol. (1992) 4(1):142–148.
  • PREISSNER K, JENNE D: Vitronectin: a new molecular connection in haemostasis. Thromb. Haemostasis (1991) 66(2): 189–194.
  • COLVIN R: Fibronectin in wound healing. In: Biology of Extracellular Matrix: A Series: Fi-bronectin (1989) Mosher D (Ed), Academic Press, San Diego.
  • SABA TM: Kinetics of plasma fibronectin: Relationship to phagocytic function and lung vascular integrit. In: Biology of Extra-cellular Matrix: A Series: Fibronectin (1989) Mosher D (Ed), Academic Press, San Diego.
  • TAMKUN J, DESimoNE D, FONDA D, PATEL R, BUCK C, HoRwrrz A, HYNES R: Structure of integrin, a glycoprotein involved in the transmembrane linkage between fibronectin and actin. Cell (1986) 46:271–282.
  • HYNES R: Integrins: A family of cell surface receptors. Cell (1987) 48:549–554.
  • First classification of the integrin family and a thorough contemporary review.
  • HYNES R: Integrins: Versatility, modulation and signaling in cell adhesion. Cell (1992)69: 11–25.
  • Classic update of the 1987 review by a leading researcher.
  • ALBELDA S, BUCK C: Integrins and other cell adhesion molecules. FASEB J. (1990) 4:2868–2880.
  • BRIESEWITZ R, EPSTEIN M, MARCANTONIO E: Expression of Native and Truncated Formsof the Human Integrin alpha-1 Subunit. J. Biol. Chem. (1993) 268(4):2989–2996.
  • Cloning of cDNAs encoding the human a integrin subunit showed that secretion of a soluble truncated a-1 subunit required dimerization with soluble 131. Native and soluble c43 dimers appeared to be formed independently, suggest-ing the involvement of transmembrane or cytoplasmic do-mains in native heterodimer asembly.
  • LEAVESLEY D, SCHWARTZ M, ROSENFELD M, CHERESH D: Integrin P-1-mediated and 13-3-mediated endothelial cell migration is triggered through distinct signaling mecha-nisms. J. Cell Biol. (1993) 120(6):1519–1527.
  • Cell migration on collagen did not require the presence of extracellular calcium, whereas it was an absolute require-ment for vitronectin-mediated migration. Contact with Vn stimulated a rise in intracellular Ca2+ which required an extracellular calcium source, whereas there was no such effect of collagen.
  • YAMADA Y, KLEINIVIAN H: Functional do-mains of cell adhesion molecules. Curr. Opin. Cell Biol. (1992) 4:819–823.
  • DAmsKY CH, WERE Z: Signal transduction by integin receptors for extracellular ma-trix: cooperative processing of extracellu-lar information. Curr. Opin. Cell Biol. (1992) 4:772–781.
  • INGBER D: Integrins as mechanochemical transducers. Curr Opin. Cell Biol. (1991) 3:841–848.
  • GINSBERG M, DU X, PLOW E: Inside-out inte-grin signalling. Curr Opin. Cell Biol. (1992) 4:766–771.
  • BLOBEL C, WHITE J: Structure, function and evolutionary relationship of protein contain-ing a disintegrin domain. Curr Opin. Cell Biol. (1992) 4:760–765.
  • SCARBOROUGH R. ROSE J, NAUGHTON M, PHILLIPS D, NANNIZZI L, ARFSTEN A, CAMPBELL A, CHARO I: Characterization of the Integrin Specificities of Disintegrins Isolated from American Pit Viper Venoms. J. Biol. Chem. (1993) 268(2):1058–1065.
  • A series of homologous disintegrins was isolated and used to demonstrate that amino acid sequences immediately ad-jacent to the RGD site can create an extended RGD locus. The nature of this locus and the presentation of the RGD sequence may be involved in determining integrin selec-tivity and affinity. Read in conjunction with patent [113].
  • MORRISON P, EDSALL J, MILLER S: Prepara-tion and properties of serum and plasma proteins XVIII. The separation of purified fibrinogen from fraction I of human plasma. J. Am. Chem. Soc. (1948) 70:3103–3108.
  • VAHERI A, MOSHER D: High molecular weight, cell surface-associated glycoprotein (fibronectin) lost in malignant tranforma-tion. Biochim. Biophys. Acta. (1978) 516:1–25.
  • HYNES R: Fibronectins. (1990) Springer-Verlag, New York.
  • Essential reference tool for CMAP researchers: well-ref-erenced, informative, intelligent and thought-provoking.
  • SCHWARZBAUER J: Alternative splicing of fi-bronectin: three variants, three functions. BioEssays (1991) 13(10):527–533.
  • GRINNELL F: Cellular adhesiveness and ex-tracellular substrata. Int. Rev. CytoL (1978) 53:65–144.
  • PIERSCHBACHER M, Ruosuum E: The cell attachment activity of fibronectin can be du-plicated by small synthetic fragments of the molecule. Nature (1984) 309:30–33.
  • Classic paper identifying the RGDS cell adhesion motif in fibronectin.
  • D'SOUZA S, GINSBERG M, PLOW E: Arginyl-glycyl-aspartic acid (RGD): a cell adhesion TIBS (1991) 16:246–249.
  • FAULL R, KOVACH N, HARLAN J, GINSBERG M: Affinity modulation of integrin alpha-5-0-1 - regulation of the functional response by soluble fibronectin. J. Cell Bid. (1993) 121(0:155–162.
  • Use of an anti-131 monoclonal antibody suggests that the a5131 Fn integrin can exist in different affinity states. Phy-siological concentrations of soluble Fn occupy the high affinity receptors thereby inhibiting adhesion to immobi-lized Fn, whereas low affinity receptors remain unoccu-pied and are still able to mediate adhesion.
  • GRINNELL F: Fibronectin Adsorption on Ma-terial Surfaces in Blood in contact with Nat-ural and Artificial Surfaces. (1987) Leonard E, Turitto E, Vroman L (Eds), The New York Academy of Sciences, New York.
  • GuRRATE M, MULLER G, KEssLER H, AUMAILLEY M, TIMPL R: Conformation/activity stud-ies of rationally designed potent anti-adhe-sive RGD peptides. Ear. J. Biochem. (1992) 210:911–921.
  • Used two-dimensional NMR and molecular modelling in the systematic design of cyclic RGD-based penta- and hexapeptides. A range of specificities and potencies (up to 100 times the inhibitory capacity of the linear GRGDS peptide) were obtained, demonstrating the potential for generating lead structures.
  • GREENSPOON N, HERSHKOVIZ R, AWN R VARON D, SKENKMAN B, MARX G, FEDERMANS, ICAPUSTINA G, LITER O: Structural Anal-ysis of Integrin Recognition and the In-hibition of Integrin-Mediated Cell Func-tions by Novel Nonpeptidic Surrogates of the Arg-Gly-Asp Sequence. Biochemistry (1993) 32:1001–1008.
  • Construction of structural RGD mimetics demonstrated active structures containing guanidinium and carboxylic groups separated by an 11-carbon atom backbone. The RGD surrogates inhibited platelet and cell adhesion in vitro, and CD4+ T-cell mediated hypersensitivity in vivo.
  • TOMASIN1 B, MOSHER D: Vitronectin. Prog. Haem. Thromb. (1990) 10:269–305.
  • CHARO I, NANNIZZI L, SMITH J, CHERESH D: The vitronectin Receptor av133 Binds Fi-bronectin and Acts in Concert with agil in Promoting Cellular Attachment and Cel-lular Attachment and Spreading on Fi-bronectin. J. Cell Biol. (1990) 1116(1)):2795–2800.
  • Demonstration of the ability of the ability of different in-tegrins to act in concert: the av-03 Vn receptor, as well as the a5-131 Fn integrin, was shown to bind Fin in bio-chemical and cell assays.
  • HORTON M: Current Status Review Vit-ronectin receptor: tissue specific expression or adaptation to culture? InL J. Exp. PathoL (1990) 71:741–759.
  • UNDERWOOD P, BENNETT F: A comparison of the biological activities of the cell-adhesive proteins vitronectin and fibronectin. J. Cell Sci. (1989) 93:641–649.
  • Paper in a series from this group using serum specifically depleted of Fn, Vn or both to study cell attachment mech-anisms in vitro in the presence of all other serum compo-nents. Particular attention is paid to the influence of the substrate on CMAP adsorption.
  • BALE M, WOHLFAHRT L, MOSHER D, TOMASINI B, SUTTON R: Identification of Vitronectin as a Major Plasma Protein Adsorbed on Poly-mer Surfaces of Different Copolymer Com-position. Blood (1989) 74(8):2698–2706.
  • Key paper identifying Vn as a major potential contributor to cell adhesion, due to its adsorption onto surfaces in the face of competition from other serum proteins.
  • STEELE J, JOHNSON G, MCFARLAND C, DALTONB, GENGENBACH T, CHATELIER R, UNDERWOOD P, GREISER H: Roles of serum vitronectin, and fibronectin in initial attachment of hu-man vein endothelial cells, and dermal fi-broblasts on oxygen- and nitrogen-contain-ing surfaces made by radiofrequency plas-mas. J. Biomater. Sci. (Polymer Ed) (1993) In press.
  • GECHTMAN Z, SHARMA R, KREIZMAN T FRIDKIN T, SHALTIEL S: Synthetic peptides derived from the sequence around the plas-min cleavage site in vitro nectin. Use in mapping the PAI-1 binding site. FEBS Lett. (1993) 315(3):293–297.
  • Study using a series of 8 peptides derived from the plas-min cleavage site in Vn to map its binding site for plas-minogen activator inhibitor. Plasmin splits this site in two, thereby reducing the affinity of Vn for PAT, with haemo-static implications.
  • ENGEL J: Laminins and Other Strange Proteins. Biochemistry (1992) 31(44):10643–10651.
  • SONNENBERG A: Laminin receptors in the in-tegrin family. Path. Biol. (1992) 40(8):773–778.
  • TAWIL N, WILSON P, CARBororro S: Inte-grins in Point Contacts Mediate Cell Spread-ing: Factors that Regulate Integrins Accu-mulation in Point Contacts vs. Focal Con-tacts. J. Cell Biol. (1993) 120(1):261–271.
  • MECHAM R: Receptors for laminin on mam-malian cells. FASEB J. (1991) 5:2538–2546.
  • HUGHES R: Role of glycosylation in cell inter-actions with extracellular matrix. Biochem. Soc. Trans. (1992) 20:279–284.
  • WAGNER D: Cell Biology of von Willebrand factor. Anna. Rev. Cell Biol. (1990) 6:217–246.
  • KAuFivIAN R: Biological regulation of factor VIII activity. Annu. Rev. Med. (1992) 43:325–339.
  • PEERSCHKE E: Platelet Membrane Glyco-proteins. (Functional Characterization and Clinical Applications.). Clin. Pathol. (1992) 98(4):455–463.
  • HAWIGER J, TIMMONS S: Binding of Fibrinogen and von Willebrand Factor to Platelet Glycoprotein Ilb-Illa Complex. Meth. Enzy-moL (1992) 215:228–243.
  • Good practical guide for those venturing into the field of vWf and fibrinogen binding to platelets.
  • ROTH GJ: Platelets and blood vessels: the adhesion event. Immunology Today (1992) 13(3):100–105.
  • ERBAN J, WAGNER D: A 130-kDa Protein on Endothelial Cells Binds to Amino Acids 15-42 of the BB chain of fibrinogen. J. Biol. Chem. (1992) 267:2451–2458.
  • PARISE L, STEINER B, NANNIZZI L, CRISS A, PHILLIPS D: Evidence for novel binding sites on the platelet glycoprotein lib and 111a sub-units and immobilized fibrinogen. Biochem. J. (1993) 289:445–451.
  • Study showing that although RODS-mediated fibrinogen attachment to the GP(a1113/133 integrin) requiresthe intact complex, another RGD-independant mechanism also operates. The second mechanism appears to be non-covalent, irreversible, calcium independant, and may de-pend on the conformation of fibrinogen: a good example of the complexity of adhesive mechanisms.
  • RUGGERI Z: Von Willebrand factor as a tar-get for antithrombotic interventon. Circula-tion (1992) 86(Suppl 6):26–29.
  • WILLIAMS J, RUCINSKI B, HOLT J, NIEWIAROW-SKI S: Elegantin and Albolabrin purified peptides from viper venoms; homologied with the RGDS domain of fibrinogen and von Willebrand factor. Biochim. Biophys. Acta (1990) 1039:81–89.
  • HOOK M, WOODS A, JOHANSSON S, KJELLEN L, COUCHMAN JR: Functions of proteogly-cans at the cell surface. In: Functions of the proteoglycans Ciba Foundation Symposium 124, John Wiley, Chichester. (1986) 143–157.
  • GALLAGHER JT, TURNBULL JE: Heparan sul-phate in the binding and activation of ba-sic fibroblast growth factor. GlycobioL (1992) 2:523–528.
  • COSTER L, MALMSTROM A, CARLSTEDT I, FRANSSON L-A: The core protein of pro-teoheparan sulphate consists of disulphide-bonded subunits. Biochem. J. (1983) 215:417–419.
  • FRANSSON L-A, CARLSTEDT I, COSTER L, MALMSTROM A: Binding of transferrin to the core protein of fibroblast proheparan sulphate. Proc. Natl. Acad. Sci. USA (1984) 81:5657–5661.
  • MALI M, JAAKKOLA P, ARVILOMMI A-M, JALKANEN M: Sequence of human synde-can indecates a novel gene family of inte-gral membrane proetoglycans. J. Biol. Chem. (1990) 265:6884–6889.
  • RAPRAEGER A: Transformation growth fac-tor (type-beta) promotes the addition of chondroitin sulphate chains to the cell surface proteoglycan (syndecan) of mouse mammary epithelia. J. Cell Biol. (1989) 109:2509–2518.
  • CULTY M, MIYAKE K, KINCADE PW, SILORSKIE, BUTCHER EC, UNDERHILL C: The hyaluro-nate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins../. Cell Biol. (1990) 111:2765–2774.
  • HARDINGHAM TE, FOSANG AJ: Proteoglycans: many forms and may functions. FASEB .1. (1992) 6:861-870.
  • Comprehensible overview of proteoglycans basic forms.
  • UNDERHILL C: CD44: The hyaluronan re-ceptor. J. Cell Sci. (1992) 103:293–298.
  • NOONAN DM, FULLE A, VELEN'TE P et al.: The complete sequence of perlecan, a membrane heparan sulphate proteoglycan, reveals ex-tensive similarity with laminin A chain, low density lipoprotein-receptor and the neural cell adhesion molecule. J. Biol. Chem. (1991) 266:22939–22947.
  • CHIQUET-EHRISMANN R: Anti-adhesive mole-cules of the extracellular matrix. Curr Opin. Cell Biol. (1991) 3:800–804.
  • BORNSTEIN P: Thrombospondins: structure and regulation of expression. FASEB J. (1992) 6:3290–3299.
  • RIOu J, UMBHAUER M, SHI D, BOUCAUT J: Tenascin: a potential modulator of cell-ex-tracellular matrix interactions during verte-brate embryogenesis. Biol. Cell. (1992) 75:1–9.
  • SAGE E, BORNSTEIN P: Extracellular Proteins That Modulate Cell-Matrix Interactions. J. Biol. Chem. (1991) 266(23):14831–14834.
  • BUTLER W: The Nature and Significance of Osteopontin. Conn. Tiss. Res. (1989) 23:123–136.
  • VAN DER REST M, GARRONE R: Collagen family of proteins. FASEB J. (1991) 5:2814–2823.
  • Excellent summary of current structural classification of the collagens.
  • JUST M, HERBST H, HUMMEL M et al.: Un-dulin is a novel member of the fibronectin-tenascin family of extracellular matrix gly-coproteins. J. Biol. Chem. (1991) 266:17326–17332.
  • TRUEB J, TRUEB B: Type IV collagen is a variant of undulin. Eur. J. Biochem. (1992) 207:549–557.
  • LEGAN P, COLLINS J, GARROD D: The Molecu-lar Biology of Desmosomes and Hemidesmo-somes: "What's in a name?" BioEssays (1992) 14:385–393.
  • GEIGER B, AYALON O: Cadherins. Annu. Rev. Cell. Biol. (1992) 8:307–32.
  • KEELAN E, HASICARD D: CAMS and anti-CAMS: the clinical potential of cell adhesion molecules. J. R. Coll. Physicians Lond. (1992) 26(1):17–24.
  • SABA TM: Fibronectin: role in phagocytic host defence and lung vascular injury. In: Fi-bronectin in health and disease. (1989) Carsons SE (Ed) CRC Press, Boca Raton, Florida pp49–68.
  • HUMPHRIES MJ, OLDEN K, YAMADA KM: Fibronectin and cancer: Implications of cell adhesion to fibronectin for metastasis. In: Fi-bronectin in health and disease (1989) Car-sons SE (Ed) CRC Press, Boca Raton, Florida, pp161–199.
  • A detailed review and huge bibliography.
  • GRINNELL F: Fibronectin and wound healing (1984) 26:107–116.
  • GROSSMAN JE: Plasma fibronectin and fi-bronectin therpay in sepsis and critical ill-ness. Rev. Infect. Dis. (1987) 9 (Suppl 4):S420–430.
  • BROWN RA: Failure of fibronectin as an op-sonin in the host defence system. A case of competitive self inhibition? Lancet (1983) II:1058–60.
  • NISHIDA T, NAKAGAWA S, NISHIBAYASHI C, TANAKA H, MANABE R: Fibronectin enhance-ment of corneal epithelial wound healing of rabbits in vivo. Arch. Ophthalmol. (1984) 102:455–456.
  • NISHIDA T, °BASHI Y, AWATA T, MANABE R: Fibronectin a new therapy for trophic corneal ulcer. Arch. Ophthalmol. (1983) 101: 1046–1048.
  • KONO I et al.: Beneficial effect of topical fi-bronectin in patients with keratoconjunctivi-tis Sicca of Sjogren's syndrome. J. Rheuma-tol. (1985) 12:487–489.
  • LioTTA LA: Tumor invasion and metasta-sis: role of the basement membrane. Am. .1. Pathol. (1984) 117:339–348.
  • IWAMOTO Y, ROBEY FA, GRAF J et al.: YIGSR, A synthetic laminin pentapeptide, inhibits experimental metastasis formation. Science (1987) 238:1132–1134.
  • KANEMOTO T, REICH R, ROYCE L et al.: Iden-tification of an amino acid sequence from the laminin A chain that stimulates metastasis and collagenase IV production. Proc. Natl. Acad. Sci. USA (1990) 87:2279–2283.
  • ROYCE LS, MARTIN GR, KLEINMAN HK: Induction of an invasive phenotype in benign tumor cells with a laminin A-chain synthetic peptide. Invasion Metastasis (1992) 12:149–155.
  • Murine melanoma cell lines stimulated to produce type VI collagen degrading protease and to invade a matrigel sub-strate by peptide PA22–2, containing laminin sequence.
  • GRANT DS, KINSELLA JL, FRIDMAN R et al.: Interaction of endothelial cells with a laminin A-chain peptide (SIKVAV) in vitro and induction of angiogenic behaviour in vivo. J. Cell Physiol. (1992) 153:614–625.
  • WEST DC, HAMPSON IN, ARNOLD F, KUMAR S: Angiogenesis induced by degradation products of hyaluronic acid. Science (1985) 228:1324–1326.
  • First identification of this source of angiogenic activity with its implications for the importance of hyaluronan breakdown.
  • VAHERI A, STEPHENS RW, SALONEN E-M, POLLANEN J, TAPIOVAARA H: Plasminogen activation at the cell surface-matrix inter-face. Cell Differentiation and Development (1990) 32:255–262.
  • BERMAN M, MONSEAU E, LAW M, AIKEN D: Ulceration is correlated with degradation of fibrin and fibronectin at the corneal surface. Invest. Ophthal. Vis. Sci. (1983) 24:1358–1366.
  • NIMNI ME, CHEUNG DT, STRATES B, KODAMA M, SHEIK K: Bioprosthesis derived from crosslinked and chemically modified collage-nous tissues. In: Collagen (1988) Nimni ME (Ed) CRC Press, Boca Raton, Florida, Volume ppl -38.
  • Good introductory overview.
  • YANNAS IV: Regeneration of skin and nerve by use of collagen templates. In: Collagen vol III Biotechnology (1988) Nimni ME (Ed) CRC press, Florida, pp87–115.
  • An important summary of influential concepts and obser-vations in the field.
  • DOILLON CJ, SILVER FH: Collagen-based wound dressing: effects of hyaluronic acid and fibronectin on wound healing. Biomate-rials (1986) 7:3–7.
  • Darr VM, HAVERSTICK DM, O'RouRKE K et al.: Inhibition of platelet aggregation by a monoclonal antibody to human fibronectin. Proc. NatI Acad. Sci. USA (1985) 82:3844–3849.
  • JILEK F, HORMANN H: Cold insoluble globu-lin III. Cyanogen bromide and plasminoly-sis fragments containing a label introduced by transamidation. Hoppe-Seyler's Z Physiol. Chem. (1977) 358:1165–1173.
  • GAUSS-MULLER V, KLEINMAN HK, MARTIN GR, SCH1FFMANN E: Role of attachment fac-tors and attractants in fibroblast chemo-taxis. J. Lab. Clin. Med. (1980) 96:1071–1080.
  • KURKINEN M, VAHERI A, ROBERTS PJ, STENMAN S: Sequential appearance of fibronectin and collagen in experimental granulation tissue. Lab. Invest. (1980) 43:47–53.
  • HYNES RO: Wound healing, inflammation and fibrosis. In: Fibronectins (1988) Springer-Verlag, New York, pp349–364.
  • FALCONE PA, BONAVENTURA M, TURNER DC, FROMM D: The effect of exogenous fi-bronectin on wound breaking strength. Plas-tic Reconstructive Surg. (1984) 74:809–812.
  • BROWN RA, BLUNN GW, EJIM OS: Prepa-ration of orientated fibrous mats from fi-bronectin: composition and stability. Sub-mitted.
  • HYNES RO: Biosynthesis and fibrillogenesis. In: Fibronectins. (1988) Springer-Verlag, New York, pp176–199.
  • EJIM OS, BLUNN GW, BROWN RA: Produc-tion of artificial orientated mats and strands from plasma fibronectin: a morphological study. Biomaterials In press.
  • JACKSON DS: The Dermal Scar. In: Collagen in Health and Disease (1982) Weiss JB, Jayson MIV (Eds), Churchill-Livingstone, Edinburgh, pp466–473.
  • CARDARELLI PM, YAMAGATA S. IKUHIKO T, GORCSAN S. CHIANG SL, LOBI T: The collagen receptor a2-131, from MG-63 and HT 1080 cells interacts with cyclic RGD peptides. J. Biol. Chem. (1992) 267:23159–23164.
  • NISHIYAMA T, TOMIGAWA N, NAKAJMA K, HAYASHI T: Quantitative evaluation of the factors affecting the process of fibroblast-mediated collagen gel contraction by sepa-rating the process into three phases. Colla-gen Relat. Res. (1988) 8:259–273.
  • TIOLLIER J, DUMAS H, TARDY M, TAYOT J-L: Fibroblast behaviour on gels of type LIII and IV human placental collagens. Exp. Cell Res. (1990) 191:95–104.
  • Trvois E, TOILLIER J, GAUCHERAND M, DUMAS H, TARDY M, THIVOLET J: In vitro and post transplantation differentiation of hu-man keratinocytes grown on the human type IV collagen film of a bilayered dermal sub-stitute. Exp. Cell Res. (1991) 193:310–319.
  • THOMPSON ICP, HANNA KD, GIPSON IK, GRAVAGNA P, WARING GO, JOHNSON-WINT B: Synthetic Epikeratoplasty in Rhesus mon-keys with human type IV collagen. Cornea (1993) 12:35–45.
  • LAQUERRIERE A, YUN J, TOILLIER J, HEMET J, TADM M: Experimental evaluation of bilay-ered human collagen as a dural substitute. .1. Neurosurg. (1993) 78:487–491.
  • MORGON A, DISANT F, TRUY E: Experimental study of collagen as eardrum graft support in dogs. Acta Otolaryngol. (1989) 107:450–455.
  • LUNDBORG G: Nerve Injury and Repair. (1988) Churchill Livingstone, Edinburgh, pp 1–31.
  • YUN J, TIOLLIER I, TARDY M etal.: Nerve re-generation using a human placental collagen type IV/IVox tube. Proceedings of the Eur-popean 7issue Repair Society (1992) 46.
  • GRANT DS, TASHIRO K-I, SEGUI-REAL B, YAMADA Y, MARTIN GR, KLEINMAN HK: Two laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro. Cell (1989) 58:933–943.
  • GRANT DS, KINSELLA J, CID MC, KLEINMAN HK: Specific Lamjnin domains mediate en-dothelial cell adhesionand angiogenesis. In: Angiogenesis in health and disease (1992) Maragoudalcis ME et al. (Eds) Plenum Press, New York pp99–110.
  • MADRI JA, WILLIAMS SK: Capillary endo-thelial cell culutres: phenotypic modulation by matrix components. J. Cell Biol. (1983) 97:153–165.
  • INGBER DE: Fibronectin controls endothelial cell gowth by modulating cell shape. Proc. Natl. Acad. Sci. USA (1990) 87:3579–83.
  • Pivotal observations linking CMAP function with growth factor action.
  • BREM SS, ZAGZAG D, TSANACLIS AMC, GATLEY S, ELKOUBY M-P, BREIN SE: In-hibition of angiogenesis and tumour growth in the brain: suppression of endothelial cell turnover by penicillamine and the depletion of copper: an angiogenic co-factor. Am. J. Pathol. (1990) 137:1121–1142.
  • AuERBAcH R: Patterns of tumour metasta-sis: organ selectivity in the spread of cancer cells. Lab. Invest. (1988) 58:361–364.
  • Cox DA, KiNz S. CERLETTI N, MCMAS'TER GK, BuRic RR: Wound healing in aged an-imals - effects of locally appled TGF-B2 in different model systems. In: Angiogenesis (1992) Steiner R et al. (Eds) Birkhauser-Ver-lag, Basel, pp287–295.
  • BROWN RA, WEISS JB: Neovascularisation and its role in the osteoarthritic process. Ann. Rheum. Dis. (1988) 47:881–885.
  • STEVENS CR, WILLIAMS RB, FARRELL AJ, BLAKE DR: Hypoxia and inflammatory syn-ovitis: observations and speculations. Ann. Rheum. Dis. (1991) 50:124.
  • FRIDMAN R, GIACCONE G, KANEmoro T, MARTIN GR, GAZDAR AF, MULSHINE JL: Re-constituted basement membrane (matrigel) and laminin can enhance the tumorigenic-ity and the drug resistance of small cell lung cancer cell lines. Proc. Natl. Acad. Sci. USA (1990) 87:6698–6702.
  • MAST BA, FLOOD LC, HAYNES JH et al.: Hyaluronic acid is a major component of the matrix of foetal rabbit skin and wounds: im-plications for healing and regeneration. Ma-trix (1991) 11:63–68.
  • FAVARO G, SCHIAVINATO A, LANGONE F, SPIN' S, LINT E, GOVONI E: Peripheral nerve re-generation through resorbable and perma-nent nerve guides: A comparison in long term pathologic alterations. Proceedings of the Eurpopean Tissue Repair Society (1992) 47.
  • BROWN RA, MORE J, EJIM OS: Preparation of a gold-binding conjugate containing gold thiomalate. Artzenmietel Forcsh. (1993) 43: 682–685.
  • BROWN RA, WELLS TM: Interaction and aggregation of gold thiomalate (myocrysin) and poly L-lysine. J. Phann. Pharmacol. (1992) 44:467–471.
  • PESSA ME, BLAND KI, COPELAND EM: Growth factors and determinants of wound repair. J. Surg. Res. (1987) 142:201–217.
  • BURGESS WH, MACIAG T: The heparin bind ing growth factor family of proteins. Ann. Rev. Biochem. (1989) 58:575–606.
  • Review of FGF-like growth factor family with classifica-tion based on ability to bind to heparin.
  • ANDRADE JD, HLADY V: Protein Adsorp-tion and Materials Biocompatibility: A Tuto-rial Review and Suggested Hypotheses. Adv. Polym. Sci. (1986) 79:1–63.
  • BRASH JL: The fate of Fibrinogen following adsorption at the blood biomaterial inter-face. In: Blood in contact with Natural and Ar-tificial Surfaces. (1987) Leonard E, Turitto E, Vroman L (Eds), The New York Academy of Sciences, New York.
  • OKADA T, IKADA Y: In vitro and in vivo diges-tion of collagen covalently immobilized onto the silicone surface. J. Biomed. Mater Res. (1992) 26:1569–1581.
  • GRINNELL F: Focal adhesion sites and the re-moval of substratum-bound fibronectin. J. Cell. Biol. (1986) 103:2697–2706.
  • WILLIAMS DF: A model for biocompatibil-ity and its evaluation. J. Biomed. Eng. (1989) 11:185–191.
  • CHENG S-S, CHITTUR K, SUKENIK C, CULP L, LEWANDOWSKA K: The conformation of fibronectin on self-assembled monolayers with different surface composition: an FT-IR/ATR study. Nineteenth Annual Meeting of the Society for Biomaterials (1993) Birming-ham, AL, USA, 308.
  • UNDERWOOD P, STEELE J, DALTON B: Effects of polystyrene surface chemistry on the bio-logical activity of solid phase fibronectin and vitronectin, analysed with monoclonal anti-bodies. J. Cell Sci. (1993) 104(3):793.
  • BRUNSTEDT M, ZIATS N, ROSE-CAPRARA V HILTNER P. ANDERSON J, LODOEN G, PAYET C: Attachment and proliferation of bovine aortic endothelial cells onto additive modi-fied poly(ether urethane ureas). J. Biomed. Mater Res. (1993) 27:483–492.
  • Typical study of in vitro cell/CMAP/surface interactions from a leading biomaterials group, well-referenced and discussed in context of current literature.
  • HERBERT C, DRUMHELLER P, ELBERT D, PATHAK C, HUBBELL J: Cell-Nonadhesiveness of pHEMA hydrogel copolymerized with bi-functional PEG diacrylate and EMA is de-pendent on PEG concentration and molecu-lar weight. Nineteenth Annual Meeting of the Society for Biomaterials (1993) Birmingham, AL, USA, 177.
  • MERRILL EW: Distinctions and Correspondences among Surfaces Contacting Blood in Blood in contact with Natural and Artificial Surfaces. (1987) Leonard E, Turitto E, Vroman L (Eds), The New York Academy of Sciences, New York.
  • Brief review of surface properties in relation to adsorption of blood proteins onto biomaterials.
  • ANDERSON J, KOTTKE-MARCHANT K: Platelet Interactions with Biomaterials and Artificial Devices. CRC Crit. Rev. Biocompat. (1985) 1(2): 111–204 .
  • LIN HB, GARCIAECHEVERRIA C, ASAKURA S. SUN W, MOSHER DF, COOPER SL: Endothelial Cell Adhesion on Polyurethanes Containing Covalently Attached RGD-Peptides. Bioma-terials (1992) 13(13):905–914.
  • HUBBELL J, MASSIA S, DESAI N, DRUMHELLER P: Endothelial cell-Selective materials for tis-sue engineering in the vascular graft via a new receptor. BioffechnoL (1991) 9:568–572.
  • Good study identifying REDV as an adhesive sequence for endothelial cells but not platelets and subsequently grafting it to substrates for vascular applications. Read in conjunction with reference [1481.
  • MASSIA S, HUBBELL J: Vascular Endothelial Cell Adhesion and Spreading Promoted by the Peptide REDV of the IIICS Region of Plasma Fibronectin Is Mediated by Integrin a4[31. J. Biol. Chem. (1992) 267(20):14019–14026.
  • Elegant study showing that endothelial cell binding to the REDV peptide is mediated via the ct4131 integrin which is not found on platelets. Potential mechanism for enhancing endothelialization without platelet adhesion.
  • RATNER B: Plasma deposition for biomedical applications: A brief review. J. Biomater. Sci. Polymer Ed. (1992) 4(1):3–11.
  • GOMBOTZ WR, HOFFMAN AS: Gas-discharge techniques for biomaterial modification. CRC Crit. Rev. Biocompat. (1987) 4(1):1–42.
  • Excellent thorough review of plasma modification and its medical applications. Recommended as a starting point for any newcomer to the field.
  • CHEHROUDI B, GOULD T, BRUNEI 1E, D: Ef-fects of a grooved titanium-coated implant surface on epithelial cell behavior in vitro and in vivo. .1. Biomat Mater Res. (1989) 23:1067–1085.
  • MEYLE J, GULTIG K: Focal adhesion sites of human fibroblasts grown on microstruc-tured surfaces. Nineteenth Annual Meeting of the Society for Biomaterials. (1993) Birming-ham, AL, USA, 283.
  • PULE° D, PRESTON K, SHAFFER J, BIZIOs R: Examination of osteoblast/orthopaedic bio-material interactions using molecular tech-niques. Biomaterials (1993) 14(2): 111–114 .
  • KLINKMANN H, IVANOVITCH P: Biocompati- bility: The need for a systems approach. J. Lab. Clin. Med. (1993) 121:203–204.
  • Commentary on the problems besetting biomaterials re-search and the need to consider the compound/material/-device/procedure/patient as a system for evaluation.
  • WEAVER D, Prrr W: Molecular dynam-ics simulations of protein interactions with polymer surfaces. Nineteenth Annual Meeting of the Society for Biomaterials. (1993) Birm-ingham, AL, USA, 179.
  • ALON R, BAYER E, WILCHEK M: Cell Adhe- sion to Streptavidin via RGD Dependent In-tegrins. Eur J. Cell. Biol. (1993) 60(1):1–11.
  • Interesting discovery that streptavidin undergoes confor-mational change following biotin binding, leading to the exposure of an RYD sequence which has high RGD homology and therefore binds cells via integrin receptors.
  • HANEIN D, SABANAY H, ADDADI L, GEIGER B: Selective interactions of cells with crystal surfaces. Implications for the mechanism of cell adhesion. J. Cell Sci. (1993) 104:275–288.
  • Novel use of calcium (R,R)-tartrate tetrahydrate crystals with two chemically equivalent but structurally distinct faces. One face was directly adhesive for cells, leading to protein-independant attachment and cell death, whilst the other showed slower cell adhesion mediated by CMAPs.
  • TRAVIS J: Biotech gets a grip on cell adhe-sion. Science (1993) 260:906–908.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.